Concepedia

Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity

Juliana Aparecida Souza, Cécile Vindis, Boris Hansel, Anne Nègre‐Salvayre, Patrice Thérond, Carlos Serrano, Sandrine Chantepie, Robert Salvayre, Éric Bruckert, M. John Chapman,

Atherosclerosis · 2007 · 126 citations · 38 references

DOI

Concepts

References

38

Continuous Monitoring of<i>in Vztro</i>Oxidation of Human Low Density Lipoprotein

H. Esterbauer, G Striegl, Herbert Puhl et al. · Free Radical Research Communications · 1989 · 1.8K citations

, , +16

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

Charles M. Alexander, Pamela B. Landsman, Steven M. Teutsch et al. · Diabetes · 2003 · 1.5K citations · Full text

, , +16

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

Lemin Zheng, Benedicta N. Nukuna, Marie-Luise Brennan et al. · Journal of Clinical Investigation · 2004 · 657 citations

, , +16

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

Lemin Zheng, Benedicta N. Nukuna, Marie‐Luise Brennan et al. · Journal of Clinical Investigation · 2004 · 647 citations · Full text

, , +16

HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3

Jerzy‐Roch Nofer, Markus van der Giet, Markus Tölle et al. · Journal of Clinical Investigation · 2004 · 620 citations · Full text

, , +17